Investing in Diagnostics

The planned panel discussion titled “Investing in Diagnostics” will be among the most important conversations that take place at this year’s Annual Personalized Medicine Conference.

By exploring the perspectives of investors and diagnostics company executives, this discussion will provide insights on what the financial future might look like for diagnostics companies whose products make personalized medicine possible.

The panel will be moderated by Michael D. Goldberg, who has played a leading role in the founding of multiple personalized medicine companies. The participating panelists are listed below.

This discussion will not be recorded.